Surgery Partners (SGRY) Net Cash Flow (2014 - 2026)

Surgery Partners (SGRY) has 13 years of Net Cash Flow data on file, last reported at -$57.6 million in Q1 2026.

• Quarterly Net Cash Flow fell 43.28% year-over-year to -$57.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$47.0 million (down 206.58% YoY) and the FY2025 annual result came in at -$29.6 million, down 140.22% from the prior year.
• Net Cash Flow fell to -$57.6 million in Q1 2026 per SGRY's latest filing, from $36.5 million in the prior quarter.
• The five-year high for Net Cash Flow was $128.1 million in Q4 2022, with the low at -$151.5 million in Q2 2022.
• Average Net Cash Flow over 5 years is -$12.2 million, with a median of -$11.0 million recorded in 2022.
• Year-over-year, Net Cash Flow surged 218.95% in 2024 and sank 662.65% in 2025.
• Surgery Partners' Net Cash Flow stood at $128.1 million in 2022, then tumbled by 131.3% to -$40.1 million in 2023, then surged by 218.95% to $47.7 million in 2024, then slipped by 23.48% to $36.5 million in 2025, then slumped by 257.81% to -$57.6 million in 2026.
• Business Quant data shows SGRY's Net Cash Flow at -$57.6 million in Q1 2026, $36.5 million in Q4 2025, and -$46.7 million in Q3 2025.